Group 1: Company Overview - 加和国际控股有限公司 is a contract manufacturer based in Singapore, specializing in the production and sale of disposable medical devices and injection-molded plastic components, as well as providing mold-making services [2] - The company was established in 1981 and has become a reliable contract manufacturer for major international healthcare and medical device companies [2] - The revenue streams of the company include manufacturing and selling injection-molded plastic components for disposable medical devices and providing mold-making services [2] Group 2: Financial Performance - As of June 30, 2025, 加和国际控股 reported total revenue of 39.6624 million yuan, representing a year-on-year growth of 45% [1] - The company recorded a net profit attributable to shareholders of -1.0786 million yuan, with a year-on-year increase of 87.86% [1] - The gross profit margin stood at 21.86%, while the debt-to-asset ratio was 76.95% [1] Group 3: Market Position and Valuation - 加和国际控股's price-to-earnings (P/E) ratio is -14.52, ranking 91st in its industry, while the average P/E ratio for other healthcare companies is 4.68 [1] - The company has underperformed the Hang Seng Index, with a year-to-date decline of 28.25%, compared to the index's increase of 29.34% [1] - Other companies in the healthcare sector have P/E ratios such as 京玖康疗 at 1.53, 医汇集团 at 2.84, and 环球医疗 at 5.54 [1]
加和国际控股（08513.HK）11月28日收盘上涨7.09%，成交1.37万港元